Merck Launches Phase III Study for KRAS Hopeful, Eyes Challenge to Amgen and BMS 4/5/2024

FTC Will Have More Time to Review Novo’s $16.5B Catalent Buy 4/5/2024

Boehringer Ingelheim Cuts Staff Due to Low Humira Biosimilar Sales: Reuters 4/5/2024

Novartis to File for Pluvicto Label Expansion After Promising Phase III Data 4/5/2024

Lilly Touts 26% Q1 Revenue Growth on Strong Mounjaro Sales, Raises Full-Year Guidance by $2B 4/30/2024

Pfizer, Genmab’s ADC Tivdak Scores Full FDA Approval in Recurrent or Metastatic Cervical Cancer 4/30/2024

Enlaza Raises $100M in Series A Financing Led by JP Morgan’s Life Sciences Group 4/30/2024

J&J, BMS Lose Challenges to Medicare Drug Price Negotiation Program 4/30/2024

AstraZeneca, Daiichi Sankyo Continue Earlier-Line Breast Cancer Push with Phase III Enhertu Win 4/30/2024

Novartis, PeptiDream Ink Potential $2.7B Deal to Expand Radioligand Discovery Partnership 4/30/2024

Prime Medicine Gets FDA Okay for First Trial of Gene Editing Technique 4/30/2024

A Takeda Oncology Leader’s Passion Fuels A Patient-First Approach 4/30/2024

Ono to Buy Deciphera for $2.4B, Looks to Expand Cancer Pipeline and US Footprint 4/29/2024

BMS, Repertoire Ink Potential $1.8B Deal to Find Vaccines for Autoimmune Diseases 4/29/2024

FDA Approves First Targeted Treatment for WHIM Syndrome 4/29/2024

J&J-Partnered Addex Fails Phase II Epilepsy Study, Mulls Future of Candidate 4/29/2024

Bavarian Nordic’s Mpox Vaccine Safe, Effective at Lower Doses: Study 4/29/2024

Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT 4/29/2024

Pharma R&D ROI Spikes in 2023 as ‘Breakthroughs’ Re-Energize Industry: Report 4/29/2024

What’s Next for Obesity Therapeutics? Higher Quality Weight Loss 4/29/2024